BRAF and hairy cell leukemia: Although the activating BRAF V600E mutation could be identified as a key pathogenetic driver detectable in nearly all HCL patients [17], current data suggest that isolated BRAF mutations rather induce cell senescence and apoptosis than cell cycle progression and HCL transformation [26].